pharmaphorum

DECEMBER 4, 2022

Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event. Neuralink has been promising that the technology will be ready for clinical trials soon for some time – first saying they were around the corner back in 2019 – so the latest announcement by Musk at an update last week may be met with some scepticism.

FDA 112

FDA 112

Drug Store News

DECEMBER 4, 2022

Drug Store News kicked off its 24th annual Industry Issues Summit in person in November with retailers and the medical community sharing their strategies for collaborating to lower costs and improve outcomes.

96

96

pharmaphorum

DECEMBER 4, 2022

Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities. In fact, women hold only 11% of executive positions at Silicon Valley companies. The biopharma industry is worse, with women only accounting for 8% of CEO roles.

105

105

Drug Store News

DECEMBER 4, 2022

According to survey findings by Medifast, adults in the United States are focused on prioritizing their health and well-being in 2023.

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

DECEMBER 4, 2022

Amgen and Sanofi have said they may make cash-only offers for Horizon Therapeutics, which confirmed it was in talks with potential buyers last week, but Johnson & Johnson has ruled itself out of the running. Under Ireland’s financial regulations Amgen and Sanofi are required to acknowledge they are considering an offer – both stressing that none may arise – while J&J has to confirm it is not considering a bid for the business at the moment.

95

95

Drug Store News

DECEMBER 4, 2022

Acne Day Dots, inspired by the Acne Dot for overnight wear, are sheer and 62% thinner than its original pimple patch, the company said.

104

104

Drug Store News

DECEMBER 4, 2022

Flashfood is now available in Stop & Shop stores across New York’s Queens and Brooklyn neighborhoods.

97

97

The Guardian - Pharmaceutical Industry

DECEMBER 4, 2022

The risk of getting gout has a lot to do with our genes and little to do with diet, says GP Ayo Ajanaku. Plus, sufferers Kevin Hughes and Jared West on drugs that have helped them Daniel Lavelle is mentions that gout was historically called “the rich man’s disease” ( At 35, I found out I had gout. Imagine having to give up everything you like to eat and drink, 29 November ).

71

71

Pharmacy Times

DECEMBER 4, 2022

Scott Soefje, director of Pharmacy Cancer Care and assistant professor of Pharmacy at Mayo Clinic, discusses PD-1 inhibitors and its use in non–small cell lung cancer.

Mayo Clinic 65

Mayo Clinic 65

Hospital Pharmacy Europe

DECEMBER 4, 2022

A study was unable to identify a clear temperature threshold that could be used to identify infections among hypothermic young infants. It appears that there is no suitable temperature threshold to reliably allow emergency care clinicians to identify hypothermic young infants who are at risk of a serious bacterial infection according to a retrospective study by US researchers.

Hospitals 52

Hospitals 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Med Ed 101

DECEMBER 4, 2022

Trazodone is a medication I see used in my geriatric practice on a daily basis. It is classified as a “serotonin modulator” It has some serotonin antagonist action at lower doses and may have more serotonin agonist effects at higher dosages. In this review, I will cover the most critical trazodone clinical pearls. If you […]. The post Trazodone Clinical Pearls appeared first on Med Ed 101.

Dosage 52

Dosage 52

Hospital Pharmacy Europe

DECEMBER 4, 2022

Morning physical activity is associated with the greatest risk reduction for cardiovascular disease and stroke compared to a midday pattern. Higher levels of morning physical activity are linked to the lowest risk of incident cardiovascular disease and stroke compared to those who have a midday peak pattern according to an analysis by Dutch researchers.

Hospitals 52

Hospitals 52

Drug Store News

DECEMBER 4, 2022

Leading retail pharmacy executives catch up and network at Drug Store News’ Issue Summit cocktail reception.

59

59

Hospital Pharmacy Europe

DECEMBER 4, 2022

The combination of nirmatrelvir and ritonavir appear to be safe and well tolerated when used in pregnancy among mothers infected with COVID-19. The combination of nirmatrelvir and ritonavir (brand name Paxlovid) can be safely used in women who are pregnant and infected with COVID-19 according to a case series study by researchers from Johns Hopkins University School of Medicine, Baltimore, US.

Medical Records 52

Medical Records Hospitals Vaccines 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

BioPharm

DECEMBER 4, 2022

Obtain more data without the ambiguity of traditional chromatographic and electrophoretic assays. This notebook compiles app notes generated by the Biopharmaceutical Scientific Operations Team at Waters. They illustrate key attribute monitoring workflows that have been developed to improve and streamline MAM analysis of biotherapeutic proteins.

40

40

Hospital Pharmacy Europe

DECEMBER 4, 2022

An RCT has found that the cognitive decline in early Alzheimer’s disease and amyloid burden can be significantly reduced with lecanemab. The cognitive decline and amyloid burden in patients with early Alzheimer’s disease (AD) are significantly reduced compared to placebo after 18 months of treatment with lecanemab according to the results of a randomised, double-blind, phase 3 trial by US researchers.

Hospitals 40

Hospitals 40

Drug Store News

DECEMBER 4, 2022

Generic Perforomist is used to control the symptoms of COPD in adults with COPD.

FDA 52

FDA 52

Hospital Pharmacy Europe

DECEMBER 4, 2022

Tisagenlecleucel in paediatric and young adults with relapsed/refractory acute lymphoblastic leukaemia retains durable efficacy over 3 years. Tisagenlecleucel remains effective for more than 3 years in paediatric and young adults with relapsed or refractory acute lymphoblastic leukaemia according to the results of a follow-up study by an international research group.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

DECEMBER 4, 2022

Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market. The arrival of Humira biosimilars is expected to provide cost-effective alternatives to the anti-tumor necrosis factor (TNF) biologic, but their eventual position on the market remains to be seen. Moreover, Humira’s behemoth status makes their introduction in the US particularly interesting.

Labelling 104

Labelling Communication Hospitals FDA 104